Regional evidence and international recommendations to guide lipid management in Asian patients with type 2 diabetes with special reference to renal dysfunction

• Main Authors: Lau, T.W.L, Tan, K.E.K, Choo, J.C.J, Ng, T.-G, Tavintharan, S, Chan, J.C.N
• Other Authors: DUKE-NUS MEDICAL SCHOOL
• Format: Review
• Published: 2020
• Subjects: atorvastatin; creatine kinase; ezetimibe plus simvastatin; hydroxymethylglutaryl coenzyme A reductase inhibitor; low density lipoprotein cholesterol; pitavastatin; placebo; rosuvastatin; antilipemic agent; lipid; acute kidney failure; antioxidant activity; Asia; Asian; atherogenesis; cardiovascular disease; cardiovascular risk; chronic kidney failure; clinical practice; coronary artery atherosclerosis; creatine kinase blood level; diabetic nephropathy; disease association; disease burden; dose response; drug clearance; drug efficacy; drug megadose; drug use; end stage renal disease; ethnic difference; human; kidney disease; kidney dysfunction; lifestyle modification; liver dysfunction; myalgia; non insulin dependent diabetes mellitus; pleiotropy; practice guideline; primary prevention; priority journal; Review; rhabdomyolysis; risk assessment; secondary prevention; side effect; Asian continental ancestry group; blood; complication; statistics and numerical data; Asian Continental Ancestry Group; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Hypolipidemic Agents; Lipids; Practice Guidelines as Topic; Renal Insufficiency, Chronic
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/178103
• Institution: National University of Singapore

10.1111/1753-0407.12610